Minglin Liu
Biographic Data
| ID | 7313236 |
|---|---|
| NAME | Minglin Liu |
| GIVEN NAMES | Minglin |
| FAMILY NAME | Liu |
| SIGNATURE | LIU M |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology
This research preliminarily indicates that SSM treats HCC via multiple components and pathways. EGFR/FAK/AKT are promising therapeutic targets of SSM for HCC treatment. This provides objective evidence for further mechanistic research and the future development and clinical application of SSM in HCC patients
No prominent works on this page.
Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology
This research preliminarily indicates that SSM treats HCC via multiple components and pathways. EGFR/FAK/AKT are promising therapeutic targets of SSM for HCC treatment. This provides objective evidence for further mechanistic research and the future development and clinical application of SSM in HCC patients
Apoptosis (1 work) · Biochemistry (1 work) · Biology (1 work) · Cancer Research (1 work) · Computational biology (1 work) · Computational Drug Discovery Methods (1 work) · Hepatocellular carcinoma (1 work) · Medicine (1 work) · Natural product bioactivities and synthesis (1 work) · Pharmacology (1 work)